Disphanurat, Wareeporn, and Benjaporn Srisantithum. 2022. “Efficacy and Safety of 0.15% Isobutylamido Thiazolyl Resorcinol Combined With Hyaluronic Acid Versus 0.15% Isobutylamido Thiazolyl Resorcinol or Hyaluronic Acid Alone in Melasma Treatment: A Randomized Evaluator-Blind Trial”. Asian Medical Journal and Alternative Medicine 22 (-):S117. https://doi.org/10.14456/2022s10724.